Profile: Biotica Technology Ltd. engages in the discovery and development of drugs. We have a broad pipeline of therapeutic programmes all based on our polyketide bioengineering technology. Polyketides are small molecules naturally produced in many organisms by a multi-domain enzyme and polyketide synthase (PKS). Our drug erythromycin and its semi-synthetic derivatives are used clinically to treat a range of inflammatory disorders. We provide rapamycin which is known to be active in rheumatoid arthritis and multiple sclerosis.